Skip to main content
. 2014 Feb 13;10(2):e1004159. doi: 10.1371/journal.pgen.1004159

Figure 6. The neo-XY of D. miranda and the evolution of dosage compensation in the embryo.

Figure 6

A) Female to male transcript ratios over stages for zygotic genes (allele-specific definition, see Methods) on the neo-XY (with transcripts from both the neo-X and neo-Y included), and for just the neo-X, both broken down by whether the neo-Y copy of that gene is predicted to be functional (intact ORF) or non-functional (broken ORF). See table S12 for Wilcoxon p-values comparing chromosomes over stages. B) Example genes from the neo-XY, with allele-specific transcript abundances. Every combination of predicted functionality of the neo-Y (with the assumption that genes with intact ORFs are functional, genes with broken ORFs are nonfunctional), contribution of neo-Y transcript, and predicted compensation status (relative to the predicted functionality of the neo-Y copy of the gene) is observable.